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Background: Influenza B viruses can cause morbidity and mortality in humans but due to the lack of an animal
reservoir are not associated with pandemics. Because of this, there is relatively limited genetic sequences available
for influenza B viruses, especially from developing countries. Complete genome analysis of one influenza B virus
and several gene segments of other influenza B viruses isolated from Uganda from May 2009 through December
2010 was therefore undertaken in this study.
Methods: Samples were collected from patients showing influenza like illness and screened for influenza A and B
by PCR. Influenza B viruses were isolated on Madin-Darby Canine Kidney cells and selected isolates were
subsequently sequenced and analyzed phylogenetically.
Findings: Of the 2,089 samples collected during the period, 292 were positive by PCR for influenza A or B; 12.3% of
the PCR positives were influenza B. Thirty influenza B viruses were recovered and of these 25 that grew well
consistently on subculture were subjected to further analysis. All the isolates belonged to the B/Victoria-lineage as
identified by hemagglutination inhibition assay and genetic analysis except one isolate that grouped with the
B-Yamagata-lineage. The Ugandan B/Victoria-lineage isolates grouped in clade 1 which was defined by the N75K,
N165K and S172P substitutions in hemagglutinin (HA) protein clustered together with the B/Brisbane/60/2008
vaccine strain. The Yamagata-like Ugandan strain, B/Uganda/MUWRP-053/2009, clustered with clade 3 Yamagata
viruses such as B/Bangladesh/3333/2007 which is characterized by S150I and N166Y substitutions in HA.
Conclusion: In general there was limited variation among the Ugandan isolates but they were interestingly closer
to viruses from West and North Africa than from neighboring Kenya. Our isolates closely matched the World Health
Organization recommended vaccines for the seasons.
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Influenza viruses continue to cause significant morbidity
and mortality around the world. Influenza A viruses have
attracted a lot of attention because of their potential to
cause serious pandemics with the most recent being the
2009 H1N1 virus [1]. Influenza B viruses differ from
influenza A viruses by the lack of protein basic 1 – F2
(PB1-F2) but they also have additional proteins that are* Correspondence: dkb@vetmed.mak.ac.ug; m.ducatez@envt.fr
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distribution, and reproduction in any mediumnot found in influenza A viruses such as the glycoprotein
B (NB) as well as other differences in the genome [2,3].
In addition, while influenza A viruses have a natural
reservoir in waterbirds [4], influenza B viruses do not
have an animal natural reservoir although human influenza
B viruses have been reported in seals [5], contributing to
the virus limited diversity, which explains why they do not
cause pandemics [6].
Influenza B viruses are broadly classified into two genetic
lineages (B/Victoria/2/87-like and B/Yamagata/16/88-like)
that circulate globally with unpredictable temporal and
spatial distributions [7]. These viruses have been reported
to evolve over time due to selection pressure supplied bytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and genetic types [8].
Whole genome data on influenza viruses enables a
deeper understanding of the pathogenesis, epidemiology,
and drug sensitivities of circulating viruses. While there
is an increasing amount of influenza B virus hemagglutinin
(HA) gene sequences available, information on the other
genes and their role in pathogenesis is still limited.
Moreover, more severe cases of influenza B have been
reported [9]. With advancement and ease in generating
full genome sequences for many organisms [10], it has
become critical to examine full genomes of these viruses
in order to create a more robust understanding of the
evolution and pathogenesis of influenza B viruses to
support advances in new technologies for vaccine design
and other control strategies. We describe herein the full
genome analysis of one influenza B virus and several
gene segments of other influenza B viruses isolated in
Uganda in 2009 and 2010.
Results
Influenza B occurrence and antigenic characterization
The viruses were isolated from 2,089 patients showing
influenza-like illness (ILI) as defined (a fever (38°C) plus
either a cough or a sore throat within the past 72 hours)
between 2009 and 2010. The samples were obtained
from outpatients from the Makerere University Walter
Reed Project Influenza surveillance hospital sites
(Mulago, Jinja, Bugiri, Gulu and Kayunga). During this
period, there was co-circulation of influenza A and B
viruses. The overall influenza prevalence was 14.0% and
292 influenza viruses were isolated. By PCR, influenza B
accounted for 12.3% of the 292 total influenza isolates
recovered during that period. In total, 30 influenza B
viruses were isolated and confirmed by PCR and
immunofluorescence assays. However only 25 isolates
that grew consistently well on subculture were subjected
to further analysis (Table 1). From July 1st of 2009, the
pandemic H1N1 was reported in Uganda and this
peaked in October 2009. However the 2009 season was
predominated by Flu B while the 2010 season had two
peaks; the July peak by H3N2 subtype and the pandemic
peak in October 2010 (Additional file 1: Figure S7). The
ILI-symptoms were mainly observed in children below 5
years and indeed most of the influenza B isolates were
from this age-group. Table 1 summarizes the data on the
isolates analyzed in this study. Most of the influenza B
viruses tested (96%; 24/25) belonged to Victoria-lineage as
shown by their inhibition of antiserum in hemagglutination
inhibition (HI) assay with titers of 640–1280 except for B/
Uganda/MUWRP-089/2009 (HI titer: 160). The B/Uganda/
MUWRP-053/2009 virus belonged to the Yamagata lineage:
it cross-reacted with antiserum against the B/Florida/4/
2006 strain (Yamagata lineage).Sequence and phylogenetic analysis
All the Ugandan influenza B isolates belonged to the B/
Victoria-lineage as shown on Figure 1 except one isolate,
confirming the HI results. Although B/Victoria strains
have been classified into 6 genetic clades on the basis of
their HA sequences, the Uganda influenza B Victoria
lineage strains only grouped in genetic clade 1 indicating
limited genetic diversity and/or limited introductions of
viruses in the country. All B/Victoria-like Ugandan viruses
possessed the N75K, N165K and S172P substitutions,
characteristics of clade 1 B/Victoria viruses (Figure 1). No
amino acid mutation in the HA of B/Uganda/MUWRP-
089/2009 could explain its lower inhibition of antiserum
raised against B/Malaysia/2506/2004 as compared to its
counterparts. The phylogenetic analysis of the neuramin-
idase (NA) (Figure 2) as well as all of the internal gene
segments confirmed this clade 1 grouping (Additional
files 2, 3, 4, 5, 6, 7 Figures S1 to S6). Ugandan influenza B
isolates from 2009–2010 had residues 119F, 152R, and 292R
present on NA for all the sequenced virus strains. The
2009 viruses could be differentiated from the 2010 viruses
by a D35G substitution on NA.
A single Ugandan isolate, B/Uganda/MUWRP-053/
2009, the earliest isolate reported from the present
study; clustered with Yamagata-lineage viruses. Its HA
sequence clustered with clade 3 Yamagata viruses such as
B/Bangladesh/3333/2007 characterized by S150I and
N166Y substitutions (Figure 1). The strain consistently clus-
tered with clade 3 Yamagata-like viruses (Figures 1, 2, and
Additional file 4: Figure S3), although genetic sequences
could only be obtained for HA, NA, and polymerase acidic
(PA) gene segments.
We observed an apparent low variability within
Ugandan B/Victoria-like influenza isolates over the study
period. The Kimura distance (at the nucleic acid level)
ranged between 0 and 1.0% for HA (with the highest
Kimura distance between B/Uganda/MUWRP-136/2009
and B/Uganda/MUWRP-237/2010, collected 1 month
apart); and between 0.1 and 0.5% for NA (with the high-
est Kimura distance between B/Uganda/MUWRP-158/
2010 and B/Uganda/MUWRP-084/2009 or B/Uganda/
MUWRP-122/2009, collected 7 and 5 months apart,
respectively). Similarly, pairwise genetic distances at the
amino acid level (with a Poisson correction) were very
low, ranging between 0 and 0.5% for HA and between
0.2 and 0.7% for NA. Because of the low variability
among the isolates, we sequenced and analyzed the full
genome of one representative isolate (B/Uganda/
MUWRP-081/2009). We also sequenced and analyzed 5
to 7 gene segments for 11 virus strains we worked on
(out of a total of 25 isolates). For each isolate, the HA
and at least a second gene segment was sequenced.
Table 1 summarizes the sequenced genes for each Ugan-
dan isolate. Additional files of sequences used in drawing
Table 1 Ugandan isolates included in this study
Virus name Collection date Age Sentinel hospital Subtype1 HI titres Genes sequenced2
B/Uganda/MUWRP-053/2009 6-May-09 4 years Mulago Yam 1280 PA*, HA, NA*,
Uganda/MUWRP-054/2009 2-Jul-09 6 months Mulago Vic 1280 PB2, PA, HA, NA, NP, M, NS
B/Uganda/MUWRP-055/2009 7-Jul-09 13 months Mulago Vic 1280 PB2, PB1, PA, HA, NA, NS
B/Uganda/MUWRP-056/2009 7-Jul-09 12 years Mulago Vic 1280 HA, NA, NP, M, NS
B/Uganda/MUWRP-057/2009 10-Jul-09 4 years Mulago Vic 1280 HA, NA, NP, M, NS
B/Uganda/MUWRP-060/2009 27-Jul-09 66 months Mulago Vic 1280 HA, NA, NP, NS
B/Uganda/MUWRP-063/2009 28-Jul-09 13 years Mulago Vic 1280 PB2, PA, HA, NA, M, NS
B/Uganda/MUWRP-064/2009 29-Jul-09 8 years Mulago Vic 1280 PB2, PB1, PA, HA, NA, M, NS
B/Uganda/MUWRP-068/2009 6-Aug-09 18 months Mulago Vic 1280 PB2, PB1, PA, HA, NA, NS
B/Uganda/MUWRP-073/2009 13-Aug-09 14 months Mulago Vic 1280 PB2, PB1, PA, HA, NA,
B/Uganda/MUWRP-076/2009 20-Aug-09 28 months Mulago Vic 1280 HA,
B/Uganda/MUWRP-077/2009 20-Aug-09 35 months Mulago Vic 1280 PB2, PB1, HA, NA, M, NS
B/Uganda/MUWRP-078/2009 24-Aug-09 6 months Mulago Vic 1280 HA, NA,
B/Uganda/MUWRP-080/2009 25-Aug-09 12 months Mulago Vic 1280 PB1, PA, HA, NA, NS
B/Uganda/MUWRP-081/2009 26-Aug-09 35 months Mulago Vic 1280 PB2, PB1, PA, HA, NA, NP, M, NS
B/Uganda/MUWRP-083/2009 27-Aug-09 63 months Mulago Vic 1280 HA, NA,
B/Uganda/MUWRP-084/2009 27-Aug-09 10 months Mulago Vic 1280 HA, NA,
B/Uganda/MUWRP-088/2009 8-Sep-09 8 months Mulago Vic 640 HA, NA,
B/Uganda/MUWRP-089/2009 10-Sep-09 52 months Mulago Vic 160 HA, NA, NS
B/Uganda/MUWRP-115/2009 21-Oct-09 6 years Jinja Vic 1280 HA, NP, M, NS
B/Uganda/MUWRP-122/2009 23-Oct-09 6 years Bugiri Vic 1280 HA, NA, NP, M, NS
B/Uganda/MUWRP-136/2009 02-Nov-09 60 months Jinja Vic 1280 PB1, PA, HA, NP,
B/Uganda/MUWRP-154/2010 8-Jan-10 21 years Mulago Vic 640 HA, NP
B/Uganda/MUWRP-158/2010 24-Mar-10 39 months Mulago Vic 640 HA, NA, NP
B/Uganda/MUWRP-237/2010 17-Dec-10 6 months Mulago Vic 640 PB1*, PA*, HA, NA,
1 Yam: Yamagata lineage, B/Florida/4/2006-like virus; Vic: Victoria lineage, B/Malaysia/2506/2004-like virus for the 2009 isolates and B/Brisbane/60/2008-like virus
for the 2010 isolates.
2 * only partial sequence available.
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been provided as Fasta files (Additional files 8, 9, 10, 11,
12, 13, 14 and 15: Byarugaba_SFile1-8). The very low
genetic diversity observed among the available sequences
confirmed the similarities among Ugandan influenza B
strains.
Discussion
The Makerere University Walter Reed Project influenza
surveillance was initiated in 2008 following the pandemic
threat created by the H5N1 viruses which had exhibited
very high mortality rates in humans. Within the period
under this study (May 2009 through December 2010),
2,089 samples from patients showing influenza-like ill-
nesses were collected. Although it is still unclear whether
the tropics have influenza peak seasons or whether the
virus circulates year-round [11], we have previously
observed more ILI and corresponding influenza cases
around August [12]. This is still true with influenza Band the present study: during this period, the peak of
influenza activity in Uganda was observed in July and
August (with 16/25 isolated viruses sampled in July or
August). The period also coincided with the influenza
pandemic due to influenza A(H1N1)pdm09 whose first
case in Uganda was reported on July 1st 2009. This period
therefore had a co-circulation of A/H3N2, A(H1N1)
pdm09 and influenza B viruses.
In 2009, there was co-circulation of Victoria and
Yamagata lineages of influenza B viruses observed world-
wide [7] that eventually was dominated by the Victoria
lineage later in the year as indeed was observed in our
study. Co-circulation of the two influenza B viral
lineages is a well described phenomenon [13-20]. Inter-
estingly, our unique Yamagata isolate, B/Uganda/
MUWRP-053/2009, was our very first isolate (collection
date of the original specimen: 6 May 2009, Table 1),
which is concordant with a co-circulation of Victoria














































































































































Figure 1 (See legend on next page.)
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Figure 1 Phylogenetic tree of the hemagglutinin (HA) gene segment of Ugandan influenza B isolates (in bold font) at the nucleotide
level. The HA sequences of our Ugandan influenza B isolates were compared with relevant virus sequences available in GenBank and GISAID
databases: the reference strains for each lineage and group (for the Victorian lineage: B/Brisbane/60/2008, B/Victoria/304/2006, B/Uruguay/12/
2008, B/Fujian-Gulou/1272/2008, B/Singapore/19/2009, and B/Argentina/R158/2010 as representatives of group 1, 2, 3, 4, 5, and 6, respectively; for
the Yamagata lineage: B/Florida/04/2006, B/Brisbane/03/2007, and B/Bangladesh/3333/2007 as representatives of group 1, 2, and 3, respectively;
all represented in italic underlined font), as well as all the African influenza B viruses from 2008 to 2010 available in the databases (a single
representative virus was selected for strains with identical amino acid (aa) sequences). B/Uganda/MUWRP-81/2009 was identical to B/Uganda/
0514/2009, B/Uganda/MUWRP-54/2009, B/Uganda/MUWRP-55/2009, B/Uganda/MUWRP-57/2009, B/Uganda/MUWRP-60/2009, B/Uganda/MUWRP-
63/2009, B/Uganda/MUWRP-64/2009, B/Uganda/MUWRP-68/2009, B/Uganda/MUWRP-76/2009, B/Uganda/MUWRP-77/2009, B/Uganda/MUWRP-78/
2009, B/Uganda/MUWRP-80/2009, B/Uganda/MUWRP-84/2009, B/Uganda/MUWRP-115/2009, B/Uganda/MUWRP-122/2009, B/Uganda/MUWRP-
136/2009, B/Uganda/MUWRP-158/2010, and B/Uganda/MUWRP-237/2010; B/Uganda/MUWRP-73/2009 to B/Uganda/MUWRP-88/2009 and
B/Uganda/MUWRP-89/2009. The number of identical Ugandan isolates is indicated in parenthesis when necessary. Aa substitutions characteristics
of the main groups are indicated on the tree nodes. Bootstrap values (1000 replicates) >50 are indicated on the nodes. * indicate partial
sequence data.
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virus sequences were compared with World Health
Organization (WHO) vaccine strains recommended for
the period of study (WHO weekly epidemiological
reports, 2009). Our Yamagata-like isolate of 2009 was
antigenically and genetically closely related to the B/
Florida/4/2006-like (Yamagata lineage) vaccine strains
recommended (WHO weekly epidemiological reports,
2010). Similarly, all our Victoria-like strains showed high
antigenic and genetic similarities with the 2009/2010
Northern hemisphere season B/Brisbane/60/2008-like
(Victoria lineage) vaccine strain that was recommended
for that season. Our study therefore confirms the switch
of influenza B lineage in 2009 and suggests a good
match between WHO vaccine recommendations and
influenza B viruses circulating in Uganda at the time.
Residues for neuraminidase inhibitor susceptibility
(119E, 152R, and 292R) have been previously reported for
influenza B viruses [21]. All of the Ugandan influenza B
isolates characterized in this study had genetic signatures
indicating that they remained susceptible to the available
neuraminidase inhibitors. It should be noted that
Uganda does not have anti-influenza drugs on their
essential list of drugs and they are therefore not routinely
used by the population. Influenza B viruses with reduced
susceptibility to neuraminidase inhibitors have been
reported elsewhere [22].
Although our isolates were highly conserved, there
was an evolution from the earlier isolates to the most
recent strains. The 2009 viruses could be clearly differ-
entiated from the 2010 viruses by a D35G substitution
in the neuraminidase protein. We were not able to
determine whether this was a within-country evolution
or whether it was due to new introductions into the
country. However, it was interesting to note that the
Victoria-like Ugandan viruses were phylogenetically
closer to Northern and Western African viruses than to
viruses from their neighboring country, Kenya. All the
Ugandan Victoria-like strains grouped in only one geneticsubgroup (Clade1) indicating very limited variation among
the isolates. The majority of other Victoria-like viruses
from elsewhere during the same period also belonged to
Clade 1 although a considerable percentage of strains
clustered in other clades [7]. The number of isolates and
sampling dates may explain the geographical difference.
There is no general population vaccination in Uganda
(except for specific staff working in influenza laboratories
and a few foreign nationals) and this may explain the low
genetic diversity observed: influenza viruses evolve with
vaccine-induced selection pressure within the country.
Conclusions
The study confirmed the co-circulation of Victoria and
Yamagata lineages of influenza B as was observed else-
where although the Victoria lineage later dominated in
the year. Interestingly, our isolates had limited variation
in the genetic makeup, possibly because of no vaccin-
ation coverage in the country. Influenza surveillance is
important in Uganda as in many African countries
where the virus evolution may differ from countries with
high vaccine-induced selection pressure.
Materials and methods
Sample collection
Samples were collected from five Ugandan hospital-
based sentinel surveillance sites in Uganda established
by the Makerere University Walter Reed project namely:
Mulago National Referral Hospital in Kampala, Kayunga
District Hospital, Jinja regional referral Hospital in Jinja
District, Bugiri district hospital in Bugiri District, and
Gulu regional referral hospital in Gulu District. Naso-
pharyngeal and throat samples were collected from
individuals aged 6 months or older with influenza-like
symptoms at the outpatient clinics under routine
surveillance for influenza like illness which was ongoing
since 2008. The inclusion criteria for enrollment were
fever (≥38°C) plus either cough or sore throat within the





















































































































Figure 2 (See legend on next page.)
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Figure 2 Phylogenetic tree of the neuraminidase (NA) gene segment of Ugandan influenza B isolates (in bold font) at the nucleotide
level. The NA sequences of our Ugandan influenza B isolates were compared with relevant virus sequences available in GenBank and GISAID
databases: the reference strains for each lineage and group (for the Victorian lineage: B/Brisbane/60/2008, B/Victoria/304/2006, B/Uruguay/12/
2008, B/Fujian-Gulou/1272/2008, B/Singapore/19/2009, and B/Argentina/R158/2010 as representatives of group 1, 2, 3, 4, 5, and 6, respectively; for
the Yamagata lineage: B/Florida/04/2006, B/Brisbane/03/2007, and B/Bangladesh/3333/2007 as representatives of group 1, 2, and 3, respectively;
all represented in italic underlined font), as well as all the African influenza B viruses from 2008 to 2010 available on the databases (a single
representative virus was selected for strains with identical amino acid (aa) sequences). The NA aa sequence of B/Uganda/MUWRP-054/2009 was
identical to the one of B/Uganda/MUWRP-055/2009, B/Uganda/MUWRP-056/2009, B/Uganda/MUWRP-057/2009, B/Uganda/MUWRP-063/2009, B/
Uganda/MUWRP-068/2009, B/Uganda/MUWRP-080/2009, and B/Uganda/MUWRP-083/2009; B/Uganda/MUWRP-060/2009 to B/Uganda/MUWRP-
073/2009, B/Uganda/MUWRP-088/2009, and B/Uganda/MUWRP-089/2009; B/Uganda/MUWRP-077/2009 to B/Uganda/MUWRP-078/2009; B/
Uganda/0519/2009 to B/Uganda/MUWRP-136/2009. The number of identical Ugandan isolates is indicated in parenthesis when necessary. Aa
substitutions characteristics of the main groups are indicated on the tree nodes. Bootstrap values (1000 replicates) >50 are indicated on the
nodes. * indicate partial sequence data.
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consent to participate in the surveillance study was
excluded. All participants/caretakers were informed
about the study and consented to participate in the
study by signing (or by a thumbprint if unable to write)
a consent form if 18 yrs or older. For children aged less
than 8 yrs, their parents/guardians signed the informed
consent form while for minors aged 8 to 17 yrs, they to-
gether with their parents/guardians signed the consent
form. Nasopharangeal and throat swab samples were
collected using a dacron swab in a 2-ml cryovial contain-
ing virus transport medium. After collection, the sam-
ples were immediately stored at −196°C in a liquid
nitrogen dry shipper or kept on ice if the samples were
to be delivered to the laboratory in less than 8 hours. All
samples were transported to Makerere University Walter
Reed Influenza Research Laboratories for analysis. The
study was approved by the Makerere University School
of Public Health Institutional Review Board, the US
Army Research and Material Command, and the Uganda
National Council for Science and Technology.
Influenza B screening by RT-PCR
Viral RNA was extracted from all samples by using the
QIAamp Viral RNA mini kit (Qiagen) according to the
manufacturer’s directions. RT-PCR of the extracts was
performed by using a Qiagen One-Step RT-PCR kit
according to the manufacturer’s instructions, with the
following influenza B matrix gene primers Bfwd: 50
GAGACACAATTGCCTACCTGCTT 30 and Brev: 50
TTCTTTCCCACCGAACCAAC 30 (TAGc, Copenhagen)
as described [23]. Briefly, the 25-μl reaction volume
contained 5 μl of 5x PCR buffer, 13 μl of RNAse-free H20,
1 μl of 10 mmol/L dNTPs, 1.5 μl of 10 nmol/L reverse
primer, 1.5 μl of 10 nmol/L forward primer, 1 μl of enzyme
mix (Taq DNA polymerase and reverse transcriptase), and
2 μl of viral RNA extract. Amplification was carried out in
an Applied Biosystems Veriti 96-well thermocycler with a
single reverse transcription step of 50°C for 30 min, “hot
start PCR” (95°C) for 15 sec, forty 30-sec denaturationcycles at 95°C, 30 sec of primer annealing at 55°C, 1 min
of extension at 72°C, and further extension for 10 min at
72°C. The samples (including a known positive control)
were then separated on a 1% agarose gel with a 50-bp
marker. The primers amplified a 250-bp segment of the
matrix gene in influenza B–positive samples; this product
was visualized and documented in a Biorad Gel Doc XR
imager.
Virus isolation and subtyping
PCR-positive samples (100 μl) were inoculated on 70%-90%
confluent Madin-Darby Canine Kidney cell line (MDCK)
(NBL2; American Type Culture Collection (ATCC)
Rockville, Md.) in flat-sided tubes after pre-treatment with
TPCK-trypsin to facilitate virus entry. Tubes were capped
loosely, incubated in a tissue culture incubator at 37°C with
5% CO2, and observed daily for 10 days for cytopathic
effects by light microscopy using an inverted microscope.
When cytopathic effects were observed, influenza virus was
confirmed by immunofluorescence assay with antibodies
against influenza B using Influenza B DFA kits according to
the manufacturers (Light Diagnostics) and PCR as above.
The isolates were subtyped by HI assay using reference sera
obtained from the WHO. All isolates were stored at −80°C
until further characterization.
Sequencing
Sequencing was performed at the Center of Excellence
for Influenza Research and Surveillance (CEIRS)/ WHO
Collaborating Center for the Ecology of Influenza in
Animals at St. Jude Children’s Research Hospital,
Memphis, TN. RNA was similarly extracted from 25
isolates isolated between 2009 and 2010 using RNA
extraction kits (Qiagen). RT-PCR was carried out for
individual gene fragments with primers and PCR
conditions as described in Table 2. The different fragments
were run on a 1% gel and purified by gel purification
kits (Qiagen). Sanger sequencing method was carried
out on all the segments using the same primers as used
for the PCR.
Table 2 Primer sets used for RT-PCR amplification of the eight vRNAs of Ugandan influenza B isolates
Gene Forward primer Reverse primer Source
PB1 Bm-PB1b-1: TATTCGTCTCAGGGAGCAGAAGCGGAGCCTTTAAGATG Bm-PB1b-1200R:
TATTCGTCTCGATGCCGTTCCTTCTTCATTGAAGAATGG
1
PB1 Bm-PB1b-1220: TATTCGTCTCGGCATCTTTGTCGCCTGGGATGATGATG Bm-PB1b-2369R: ATATCGTCTCGTATTAGTAGAAACACGAGCCTT 1









PB2 BPB2-1045F: GGGAACGGAACAATACAGAAG BPB2-1320R: CAAAAAATATCGTTGGAGTTG 2






PA BPA-510F GGGAGAGTGCTAAGCAGACT BPA-1430R: TCCCATGCTGGCATTGCTTTCA 2
PA BPA-940F: GAAAAGTACTCAACACTAC BPA-2020R TCCTTTAATGCTTGAATCAACAG 2
HA BHA-1F: ATGAAGGCAATAATTGTACT BHA-700R: CATAATGTGTGGTCACTCC 2
HA BHA-673F: CCCCAGAAGTTCACCTCATC BHA-1742R: CCCTTATAGACAGATGGAGC 2





NA Bm-NAb-1: TATTCGTCTCAGGGAGCAGAAGCAGAGCA Bm-NAb-1557R: ATATCGTCTCGTATTAGTAGTAACAAGAGCATTTT 1
NA BNA-716F: GGGGAAATTGTTATCTTA BNA-1410R: CCATTCCTCCATTACAGAGCC 2
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The sequences obtained were analyzed using Bioedit
Software version 5.0.9 and aligned with Clustal W [25].
Phylogenetic analysis was performed using the Neighbor-
Joining algorithm and pairwise deletion using the MEGA
version 5.05 program [26] and trees were un-rooted. The
number of bootstrap replications was set to 1,000, and
bootstrap values above 50 were labeled on major tree
branches for reference. The Ugandan virus strains were
clustered on the basis of nucleotides, and only dominant
clusters were used to infer phylogenetic relationships. The
analysis included sequences from representative isolates
from different regions of the world available in GenBank
and the sequences of both Yamagata and Victoria lineage
vaccine strains recommended by WHO for both the south-
ern and northern hemispheres for the influenza seasons
from 2008 to 2010. The latter viruses were also used as
references to compare the amino acid substitutions seen in
the Ugandan sequences. The sequences viruses used in the
phylogenetic tress are presented in Additional files 1, 2, 3,
4, 5, 6, 7, and 8 representing sequences used for Figures 1
and 2 and Additional files 2, 3, 4, 5, 6, 7 Figures S1–S6
respectively.Accession numbers
The complete gene sequences of the isolates analyzed in
this study were deposited in Genbank with accession
numbers JX427060- JX427104. The isolates with exactly
similar sequences were not included in the Genbank
instead they were represented by one sequence and they
have been indicated in the phylogenetic tree legends.Additional files
Additional file 1: Figure S7. Seasonality of influenza in Uganda during
the May 2009 to Dec 2010 season.
Additional file 2: Figure S1. Phylogenetic tree of the protein basic 2
(PB2) gene segment of Ugandan influenza B isolates (in bold font) at the
nucleotide level. The PB2 sequences of our Ugandan influenza B isolates
were compared with relevant virus sequences available on GenBank and
GISAID databases: the available reference strains (for the Victorian lineage:
B/Brisbane/60/2008 and B/Fujian-Gulou/1272/2008, as representatives of
group 1 and 4, respectively; for the Yamagata lineage: B/Florida/04/2006 and
B/Bangladesh/3333/2007 as representatives of group 1 and 3, respectively; all
represented in italic underlined font). No 2008–2010 African influenza B
viruses PB2 gene sequence was available on the databases. Bootstrap values
(1000 replicates) >50 are indicated on the nodes.
Additional file 3: Figure S2. Phylogenetic tree of the protein basic 1
(PB1) gene segment of Ugandan influenza B isolates (in bold font) at the
Byarugaba et al. Virology Journal 2013, 10:11 Page 9 of 10
http://www.virologyj.com/content/10/1/11nucleotide level. The PB1 sequences of our Ugandan influenza B isolates
were compared with relevant virus sequences available on GenBank and
GISAID databases: the available reference strains (for the Victorian lineage: B/
Brisbane/60/2008 and B/Fujian-Gulou/1272/2008, as representatives of group
1 and 4, respectively; for the Yamagata lineage: B/Florida/04/2006 and B/
Bangladesh/3333/2007 as representatives of group 1 and 3, respectively; all
represented in italic underlined font). No 2008–2010 African influenza B
viruses PB1 gene sequence was available on the databases. The aa
sequences of B/Uganda/MUWRP-055/2009, B/Uganda/MUWRP-068/2009, B/
Uganda/MUWRP-073/2009, B/Uganda/MUWRP-080/2009, and B/Uganda/
MUWRP-081/2009 were identical and only B/Uganda/MUWRP-081/2009 is
shown on the tree. Bootstrap values (1000 replicates) >50 are indicated on
the nodes. * indicate partial sequence data.
Additional file 4: Figure S3. Phylogenetic tree of the protein acidic
(PA) gene segment of Ugandan influenza B isolates (in bold font) at the
nucleotide level. The PA sequences of our Ugandan influenza B isolates were
compared with relevant virus sequences available on GenBank and GISAID
databases: the available reference strains (for the Victorian lineage: B/
Brisbane/60/2008 and B/Fujian-Gulou/1272/2008, as representatives of group
1 and 4, respectively; for the Yamagata lineage: B/Florida/04/2006 and B/
Bangladesh/3333/2007 as representatives of group 1 and 3, respectively; all
represented in italic underlined font). No 2008–2010 African influenza B
viruses PA gene sequence was available on the databases. The aa sequences
of B/Uganda/MUWRP-055/2009 and B/Uganda/MUWRP-080/2009 were
identical and only B/Uganda/MUWRP-055/2009 is shown on the tree.
Bootstrap values (1000 replicates) >50 are indicated on the nodes. * indicate
partial sequence data.
Additional file 5: Figure S4. Phylogenetic tree of the nucleoprotein
(NP) gene segment of Ugandan influenza B isolates (in bold font) at the
nucleotide level. The NP sequences of our Ugandan influenza B isolates
were compared with relevant virus sequences available on GenBank and
GISAID databases: the available reference strains (for the Victorian lineage:
B/Brisbane/60/2008 and B/Fujian-Gulou/1272/2008, as representatives of
group 1 and 4, respectively; for the Yamagata lineage: B/Florida/04/2006
and B/Bangladesh/3333/2007 as representatives of group 1 and 3,
respectively; all represented in italic underlined font). No 2008–2010
African influenza B viruses NP gene sequence was available on the
databases. The aa sequences of B/Uganda/MUWRP-056/2009, B/Uganda/
MUWRP-057/2009, B/Uganda/MUWRP-060/2009, B/Uganda/MUWRP-122/
2009, and B/Uganda/MUWRP-032/2010 were identical and only B/
Uganda/MUWRP-056/2009 is shown on the tree. Bootstrap values
(1000 replicates) >50 are indicated on the nodes.
Additional file 6: Figure S5. Phylogenetic tree of the matrix protein (M)
gene segment of Ugandan influenza B isolates (in bold font) at the
nucleotide level. The M sequences of our Ugandan influenza B isolates
were compared with relevant virus sequences available on GenBank and
GISAID databases: the available reference strains (for the Victorian lineage:
B/Brisbane/60/2008 and B/Fujian-Gulou/1272/2008, as representatives of
group 1 and 4, respectively; for the Yamagata lineage: B/Florida/04/2006
and B/Bangladesh/3333/2007 as representatives of group 1 and 3,
respectively; all represented in italic underlined font), as well as all the
African influenza B viruses from 2008 to 2010 available on the databases:
B/Egypt/0945/2010, B/Kenya/2050/2010, and B/Kenya/2067/2010. The aa
sequences of B/Uganda/MUWRP-054/2009, B/Uganda/MUWRP-056/2009,
B/Uganda/MUWRP-057/2009, B/Uganda/MUWRP-063/2009, B/Uganda/
MUWRP-064/2009, B/Uganda/MUWRP-077/2009, and B/Uganda/MUWRP-
122/2009 were identical and only B/Uganda/MUWRP-054/2009 is shown
on the tree. The number of identical Ugandan isolates is indicated in
parenthesis when necessary. Bootstrap values (1000 replicates) >50 are
indicated on the nodes.
Additional file 7: Figure S6. Phylogenetic tree of the non-structural
protein (NS) gene segment of Ugandan influenza B isolates (in bold font)
at the nucleotide level. The NS sequences of our Ugandan influenza B
isolates were compared with relevant virus sequences available on
GenBank and GISAID databases: the available reference strains (for the
Victorian lineage: B/Brisbane/60/2008, B/Fujian-Gulou/1272/2008, B/
Singapore/19/2009, and B/Argentina/158/2010, as representatives of
group 1, 4, 5, and 6, respectively; for the Yamagata lineage: B/Florida/04/
2006 and B/Bangladesh/3333/2007 as representatives of group 1 and 3,respectively; all represented in italic underlined font), as well as all the
African influenza B viruses from 2008 to 2010 available on the databases.
A single representative virus was selected for strains with identical amino
acid (aa) sequences: the NS aa sequence of B/Uganda/MUWRP-081/2009
was identical to the one of B/Uganda/MUWRP-054/2009, B/Uganda/
MUWRP-055/2009, B/Uganda/MUWRP-057/2009, B/Uganda/MUWRP-060/
2009, B/Uganda/MUWRP-063/2009, B/Uganda/MUWRP-068/2009, B/
Uganda/MUWRP-077/2009, B/Uganda/MUWRP-080/2009, B/Uganda/
MUWRP-089/2009, B/Uganda/MUWRP-115/2009, and B/Uganda/MUWRP-
122/2009. The number of identical Ugandan isolates is indicated in
parenthesis when necessary. Bootstrap values (1000 replicates) >50 are
indicated on the nodes.
Additional file 8: Byarugaba_SFile 1. Sequences of representative
isolates used for drawing the phylogenetic tree of the haemagglutinin
protein (HA) gene segment in Figure 1.
Additional file 9: Byarugaba_SFile 2. Sequences of representative
isolates used for drawing the phylogenetic tree of the neuraminidase protein
(NA) gene segment in Figure 2.
Additional file 10: Byarugaba_SFile 3. Sequences of representative
isolates used for drawing the phylogenetic tree of the protein basic 2
(PB2) gene segment of PPTX additional file 2 Figure S1.
Additional file 11: Byarugaba_SFile 4. Sequences of representative
isolates used for drawing the phylogenetic tree of the protein basic 1
(PB1) gene segment of PPTX additional file 3 Figure S2.
Additional file 12: Byarugaba_SFile 5. Sequences of representative
isolates used for drawing the phylogenetic tree of the protein acidic
(PA) gene segment of PPTX additional file 4 Figure S3.
Additional file 13: Byarugaba_SFile 6. Sequences of representative
isolates used for drawing the phylogenetic tree of the nucleoprotein (NP)
gene segment of PPTX additional file 5 Figure S4.
Additional file 14: Byarugaba_SFile 7. Sequences of representative
isolates used for drawing the phylogenetic tree of the matrix protein (M)
gene segment of PPTX additional file 6 Figure S5.
Additional file 15: Byarugaba_SFile 8. Sequences of representative
isolates used for drawing the phylogenetic tree of the non-structural
protein (NS) gene segment of PPTX additional file 7 Figure S6.
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